Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection

Phase 1/2 Completed 72 enrolled Andalusian Network for Design and Translation of Advanced Therapies

RandomizedParallel-groupOpen-labelTreatment

Summary

Phase I / II multicentre, randomized and controlled clinical trial to evaluate the efficacy of treatment with hyperimmune plasma obtained from convalescent antibodies of COVID-19 infection.

Timeline

Start: 2020-04-23
Primary completion: 2020-12-30
Completion: 2020-12-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Hyperimmune plasma	Protein / enzyme biologic	—	—

Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection

Summary

Timeline

Drugs

Indications